They have been helping patients of all ages for 85 years. They create medicines for headaches, heartaches and those used in hospitals to save lives. They also enjoy the trust of doctors and pharmacists and work with them to help ensure healthy and long life for patients.
They are a leading player on the Polish pharmaceutical market and one of the major drug manufacturers in the region of Central and Eastern Europe, Central Asia and the Caucasus. The company’s history goes back to 1935. Based on their rapid development, expansion to foreign markets and capital investments, they have become a strong multinational pharmaceutical group employing over 7,500 people and offering modern drugs, substances and innovative solutions to patients and business partners from all corners of the world. Every year, approximately 400 million packages of medicines are shipped from Polpharma Group’s factories to help people in 35 countries. Their pharmaceutical substances are exported to over 60 countries, including the highly developed markets of the United States, Japan and Korea.
They focus on quality, safety and innovation in all spheres of their activity. Based on a broad portfolio of approx. 750 products, they are able to support patients in the therapy and prevention of the most common diseases. Their fields of expertise include cardiology, neurology, ophthalmology, pulmonology, gastroenterology, and dermatology. They collaborate with scientists and constantly invest in new products and advanced technologies to provide patients with innovative therapeutic solutions, as well as give their employees access to state-of-the-art knowledge and broad development prospects. Through the Polpharma Scientific Foundation, they fund research projects in the fields of pharmacy and medicine, and award scholarships and grants to young scientists. They attach importance to corporate social responsibility, and pursue their goals while respecting social and environmental concerns and the highest ethical standards.
Their main business markets are Poland, Kazakhstan and Russia. The Polpharma Group comprises the following Polish companies: Zakłady Farmaceutyczne Polpharma SA, branches in Starogard Gdański, Sieradz, Nowa Dęba, Duchnice and Office in Warsaw, Polfa Warszawa S.A., as well Santo (Chimpharm), which is a leading pharmaceutical company in Kazakhstan. Their strategic partners are Akrikhin in Russia and Farmaprojects in Spain.
